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The proteins encoded by the UL13 genes of herpes simplex virus types 1 (HSV-1) and 2 (HSV-2) have been predicted
to be protein kinases. To identify the UL13 gene product, we have raised a rabbit polyclonal antiserum against a
His r Tag-HSV-1 UL13 fusion protein. The antibody specifically reacted with the 60-kDa UL13 fusion protein expressed
in Escherichia coli and also recognized 56- to 57-kDa late proteins in nuclear fractions of HSV-1- and HSV-2-infected
cells. On the other hand, novel casein kinase activity was induced at the late stage of infection when Vero cells were
infected with HSV-1 and HSV-2. The induction of the activity was most prominent in the nuclear fractions of HSV-2-
infected cells and therefore we purified the protein kinase (PK) from the nuclear extracts by successive column
chromatography (phosphocellulose, DEAE-cellulose, and hydroxyapatite) using casein as an exogenous substrate. The
final preparation of the enzyme contained a single major protein with an apparent molecular weight of 56 kDa which
was specifically reacted with the UL13 antiserum. The PK activity was optimal in the absence of NaCl and at relatively
high pH. Acidic proteins such as casein and phosvitin were efficiently phosphorylated by the PK. A basic protein,
protamine, which is the best substrate for the HSV-2 US3 PK, was not detectably phosphorylated but histone was a
relatively good substrate for the UL13 PK. Phosphoamino acid analysis revealed that the PK phosphorylated serine
and threonine but not tyrosine. Moreover the enzyme was found to be highly resistant to heparin, a potent inhibitor of
casein kinase II (CK II) and also resistant to CK I-7, a synthetic inhibitor of CK I, but very sensitive to a bioflavonoid
quercetin. These results indicate that the HSV-2 UL13 PK had unique catalytic properties different from those of cellular
CK I, CK II, and the viral PK encoded by the US3 gene. We have also determined the complete nucleotide sequence of
the HSV-2 UL13 gene. The overall amino acid homology between the HSV-2 and HSV-1 UL13 PKs was 85.9% and the
homology was highly conserved in the C-terminal region. q 1997 Academic Press
INTRODUCTION first of these genes to be identified, designated US3, was
originally found to contain motifs conserved in eukaryotic
Herpes simplex virus (HSV) is a large DNA virus whose
PK by DNA sequencing analysis (McGeoch and Davison,
genome encodes at least 84 genes, and more than 10
1986) and later the US3 gene product was shown to
virus-induced polypeptides have been shown to be asso- actually have PK activity (Frame et al., 1987; Daikoku et
ciated with specific enzyme activities (Roizman and al., 1993). The US3 PKs of HSV types 1 and 2 have appar-
Sears, 1996). These include DNA polymerase (Powell ent molecular weights of 68 and 66 kDa, respectively.
and Purifoy, 1977; Knopf et al., 1981; Nishiyama et al., Both enzymes transfer phosphate from ATP to the seryl
1984), DNA helicase (Zhu and Weller, 1992), DNA pri- or threonyl residues in basic substrates such as prot-
mase (Crute et al., 1989), thymidine kinase (Swain and amine, but not in acidic substrates such as casein
Galloway, 1983), ribonucleotide reductase (Averett et al., (Leader et al., 1991; Daikoku et al., 1993). The US3 PKs
1983; Goldstein and Weller, 1988), deoxyuridine triphos- are not essential for viral replication in cell culture and
phatase (Preston and Fisher, 1984), uracil-DNA glycosy- for the establishment of latency, but essential for the
lase (Caradonna et al., 1987), and alkaline nuclease maximum demonstration of neurovirulence (Purves et al.,
(Draper et al., 1986; Shao et al., 1993), all of which are 1987; Nishiyama et al., 1992). Although the putative sub-
synthesized as b polypeptides prior to viral DNA synthe- strates of the US3 PKs have been identified (Purves et
sis and are involved in DNA and deoxyribonucleotide al., 1991; Daikoku et al., 1994, 1995), the targets and roles
metabolism. Furthermore, the virus induces enzymes cat- of this enzyme are still a matter for speculation.
alyzing protein modification, such as protein kinase (PK) The large subunit of HSV ribonucleotide reductase
and protease (Welch et al., 1991). At present, three open also possesses a PK activity (Chung et al., 1989). This
reading frames are shown to be associated with PK. The activity is located within the N-terminal 310 amino acids,
a domain that is unique to HSV-1 and HSV-2 large sub-
units (Ali et al., 1992). The large subunit of HSV ribonucle-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 52-744-2452. E-mail: daikokut@tsuru.med.nagoya-u.ac.jp. otide reductase is induced at immediate-early times
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postinfection prior to the synthesis of the small subunit, maleimide, H-9, Staurosporin, quercetin, poly-L-lysine,
poly-L-arginine, PMSF, ditiothreiotol (DTT), heparin, andand therefore this PK is thought to play some role im-
portant for viral replication which is distinct from ribonu- other chemicals were purchased from Sigma Chemical
Co. Phosphocellulose (P-11), DEAE-cellulose (DE52), andcleotide reductase activity (Conner et al., 1995).
The third gene, UL13, has been identified as a PK- 3MM filters were from Whatman; [g-32P]ATP (6000 Ci/
mmol) and Immobilon PVDF membrane were from Amer-related gene by Smith and Smith (1989) and Chee et
al. (1989). This gene has counterparts not only in other sham International. Purified rat liver casein kinase I (CK
I) and casein kinase II (CK II) were purchased from Pro-alphaherpesviruses but also in beta- and gammaherpes-
viruses, while the US3 has counterparts only in alphaher- mega and their purity is greater than 85% pure as deter-
mined by SDS–polyacrylamide gel electrophoresispesviruses. The UL 13 product of HSV-1 has an apparent
molecular weight of 55 to 57 kDa, is produced at the late (PAGE).
phase of infection, and is incorporated into the virion as
Construction of pET-28 expression vectora structural component (Overton et al., 1992). To investi-
gate the role of the UL13 protein, recombinant viruses The UL13 gene of HSV-1 was amplified by polymerase
lacking UL13 have been constructed and the UL13 was chain reactions (PCR) using synthetic oligonucleotides
found to be also dispensable for viral replication. Purves primer-1 (CGACATATGGATGAGTCCCGCAGACAGC) and
and Roizman (1992) have reported that UL13-defective primer-2 (TCTGTCGACAGCGCGTGCCGCGCGCAC).
mutants have different patterns of protein phosphoryla- NdeI and SalI sites were incorporated into the primer-1
tion in infected cells from wild-type virus and that the and primer-2, respectively, to facilitate cloning. The PCR
UL13 product is responsible for the posttranslational pro- consisted of an initial 2-min denaturation step at 947,
cessing associated with the phosphorylation of regula- followed by 29 cycles of denaturation (947, 1 min), anneal-
tory protein a22 (Purves et al., 1993). On the other hand, ing (567, 2 min) and extension (727, 3 min). The 30th
Coulter et al. (1993) have shown that the UL13 protein is cycle concluded with a 10-min extension step. Reaction
involved in phosphorylation of the virion tegument protein mixture (100 ml) contained 0.1 mg of HSV DNA, 1 mM of
VP22. Moreover, Overton et al., (1994) have reported that primer-1 and primer-2, 2.5 U of PFU DNA polymerase,
the UL13 product is necessary to produce the virion host 0.2 mM each of deoxyribonucleoside triphosphate, 10%
shutoff effect mediated by the UL41 product. These ob- DMSO, 20 mM Tris–HCl (pH 8.8), 2 mM MgSO4 , 10 mM
servations indicate that the UL13 product play a role in KCl, 10 mM (NH4)2SO4 , 0.1% Triton X-100, and 0.1 mg/ml
the regulation of viral replication by means of the protein BSA. The PCR product (1565 bp) was isolated, digested
kinase activity. However, to the extent of our knowledge, with NdeI and SalI, and cloned in frame into the down-
there is no direct evidence that the protein possesses stream of the region encoding the initiating ATG plus six
protein kinase activity. Cunningham et al. (1992) have histidine (6xHis) residues in a Escherichia coli expres-
shown that infection of cells induces a novel protein sion vector pET-28b (Novagen, New York) to give pET-
kinase activity which phosphorylates exogenous casein, 28 UL13.
but they have failed to purify the PK activity from the HSV-
1-infected cells. Attempts have also been made to purify Preparation of polyclonal antiserum against the UL13
the UL13 protein from a cell line expressing UL13 and product
insect cells infected with recombinant-baculovirus, but
Plasmid pET-28 UL13 was transformed into E. colithey were unsuccessful (Cunningham et al., 1992;
strain BL21 (DE3) which, following induction with IPTG,Overton et al., 1992). In this study, we purified the UL13
expressed high levels of 6xHis-tagged UL13 fusion pro-protein kinase from HSV-2-infected cells and character-
tein. The UL13 fusion protein was solubilized and purifiedized its biochemical properties.
by means of an affinity column (His r Bind resin, Nova-
MATERIALS AND METHODS gen, New York) according to the protocol supplied by
the manufacture. Rabbits were subcutaneously injectedCells and viruses
with 200 mg of the purified UL13 fusion protein which
African green monkey kidney cells (Vero) were grown was emulsified with complete Freund’s adjuvant. Four
in Eagle’s minimal essential medium (MEM) supple- weeks after the first injection, the rabbits were given two
mented with 5% calf serum, 100 units of penicillin per booster injections at intervals of 2 weeks. Ten days after
milliliter and 100 mg of streptomycin per milliliter. Wild- the last boost, the rabbits were bled and antisera were
type HSV-1 strain KOS and HSV-2 strain 186 were used prepared.
and the virus stocks were prepared as described pre-
viously (Nishiyama et al., 1984). Assay of protein kinase activity
Chemicals and enzymes The standard assay mixture for the HSV UL13 PK con-
tained, in a total volume of 50 ml, 10 mM Tris–HCl (pHBovine milk a-, b-, and k-caseins, histone (H-2), prot-
amine, phosvitin, calmodulin, cAMP, spermine, N-ethyl- 8.0), 10 mM MgCl2 , 1 mM DTT, 0.1 mM [g-
32P]ATP (300
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cpm/pmol), and casein (2 mg/ml). The assays for CK I phate (pH 7.5), 100 mM NaCl) and applied onto a hydroxy-
apatite column (1 1 6 cm) preequilibrated with buffer B.and CK II were carried out according to the protocols
from the suppliers. The reaction mixture for CK I con- The column was washed with 50 ml of buffer B and
proteins were eluted with 50 ml of a linear gradient oftained 25 mM Tris–HCl (pH 7.4), 10 mM MgCl2 , 0.1 mM
[g-32P]ATP (300 cpm/pmol), and casein (2 mg/ml). For the 10 mM to 1 M potassium phosphate (pH 7.5) containing
100 mM NaCl.assay of CK II, 200 mM NaCl was added to the above
mixture. The reaction was started by the addition of en-
Western blottingzyme. After incubation at 377 for 15 min, aliquots of the
Cells were washed three times with PBS and lysedmixtures were withdrawn and spotted onto Whatman
with 21 SDS sample buffer (125 mM Tris–HCl, 10% glyc-3MM filter discs. The filter discs were washed twice for
erol, 10% SDS, 5% 2-ME, pH 6.8). Then proteins were15 min in 10% (W/V) trichloroacetic acid (TCA), three
separated by electrophoresis in 10% polyacrylamide gelstimes in 2% TCA, once in absolute ethanol, and then
in the presence of 0.1% SDS. The separated proteinsdried. The radioactivity was measured by liquid scintilla-
were electrophoretically transferred to an Immobilontion spectrometry.
PVDF transfer membrane. Nonspecific protein binding
was blocked by treating the membrane with Tris-bufferedPhosphoamino acid analysis
saline (TBS; 25 mM Tris–HCl, 150 mM NaCl, pH 7.4)
Casein was phosphorylated by the purified HSV-2 containing 3% BSA and 0.05% Tween 20 at 47 overnight.
UL13 PK in the standard assay mixture. The radioactive The membrane was washed once with TBS and incu-
casein was precipitated by addition of 10% TCA, acid bated with anti-UL13 rabbit serum diluted 300-fold in TBS
hydrolyzed, analyzed by thin-layer electrophoresis, and containing 0.1% BSA and 0.05% Tween 20 (TBS-T) at 377
visualized by autoradiography, as described previously for 1 hr. After washing three times with TBS-T, the mem-
(NG et al., 1994). Unlabeled phosphoserine, phos- brane was incubated with horse radish peroxidase
phothreonine, and phosphotyrosine was used as stan- (HRP)-conjugated anti-rabbit immunoglobulin at 377 for 1
dards and visualized with 0.2% ninhydrin. hr. The membrane was then washed three times with
TBS-T and once with TBS, treated with ECL Western
Extraction and purification procedures blotting detection system (Amersham Japan Co.), and ex-
posed to Hyperfilm-ECL (Amersham Japan Co.)Confluent monolayers of Vero cells were infected with
virus at a multiplicity of 5 PFU/cell, incubated at 377 for Sequencing of the HSV-2 UL13 open reading frame
20 hr, and harvested after washing twice with phosphate-
The UL13 gene of HSV-2 was sequenced by the primerbuffered saline (PBS). The cells were pelleted by centrifu-
extension/dideoxy chain termination method using ABIgation at 1000 rpm for 10 min and resuspended in RSB
PRISM dye terminator cycle sequencing ready reactionbuffer (10 mM Tris–HCl, 10 mM NaCl, 1.5 mM MgCl2 ,
kit (Perkin–Elmer). A 20.7-kb HindIIIB fragment of HSV-pH 7.4) and left for 5 min on ice. After adding NP-40 to
2 strain 186 DNA has been cloned into the HindIII sitea final concentration of 1%, the suspension was gently
of plasmid pACYC 184 (Tsurumi et al., 1986). The aboutmixed by vortex and separated into the nuclear and cyto-
5.5-kb fragment, which contains the complete open read-plasmic fractions by low-speed centrifugation (1500 rpm,
ing frames of the UL13, UL14, UL15, and UL16 genes of10 min). The nuclear fractions were then resuspended
HSV-2, was obtained by digesting the isolated HindIIIBin 40 ml of buffer A (20 mM Tris–HCl, 1 mM EDTA, 10
fragment with BamHI and EcoRI, and was inserted intomM 2-ME, 1 mM PMSF, 10 mg/ml aprotinin, 10% glycerol,
the multicloning site of plasmid pUC19. Primers specificpH 7.5) containing 400 mM NaCl and 1% NP-40, and
for the plasmid were used to initiate sequencing. Subse-sonicated for 30 sec six times in ice. Extracts were centri-
quent primer sequences were selected from the newlyfuged for 30 min at 15000 g at 47 and the supernatant was
determined sequences. Using a total of 12 primers, 18 todialyzed against buffer A and applied to preequilibrated
21 nucleotides in length, nucleotide sequences spanningphosphocellulose column (25 1 100 mm). The column
the entire UL13 gene were obtained. Sequences werewas washed with buffer A containing 50 mM NaCl and
determined from three clones on both DNA strands. Theproteins were eluted with a linear gradient of 50 mM to
nucleotide sequence data reported in this paper will ap-1 M NaCl in the same buffer. Fractions were collected
pear in the DDBJ, EMBL, and GenBank nucleotide se-and assayed immediately. Peak fractions from phospho-
quence databases with the following Accession Numbercellulose column chromatography were dialyzed against
AB001417.buffer A and applied onto a DEAE-cellulose column pre-
equilibrated with buffer A. The column was washed with RESULTS
400 ml of buffer A and proteins were eluted with 400 ml
Preparation of anti-UL13 product antiserumof a linear gradient of 50 mM to 1 M in buffer A. Peak
fractions from DEAE-cellulose column chromatography As a first step toward the purification of UL13 PK, a
rabbit polyclonal antiserum specific for this protein waswere dialyzed against buffer B (10 mM potassium phos-
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FIG. 1. (A) Schematic representation of the HSV genome containing the UL13 gene and strategy for the construction of the pET28 UL13. (B)
Induction of the His r Tag-UL13 fusion protein in E. coli and its detection by Western blotting. E. coli harboring plasmid pET28-UL13 was grown
in the absence (lanes 1 and 4) or presence (lanes 2 and 5) of IPTG. The His r Tag-UL13 fusion protein was purified by means of an affinity column
(lanes 3 and 6). Proteins were separated by SDS–PAGE and stained with Coomasie blue (lanes 1, 2, and 3). Samples were also probed with the
anti-UL13 antiserum (lanes 4, 5, and 6). (C) Detection of the UL13 gene product in infected cells by Western blotting. (A) Vero cells were mock-
infected (lanes 1 and 3) or infected with HSV-1 (lane 2) and HSV-2 (lane 4) and harvested at 18 hr postinfection. Nuclear fractions of mock-infected
or HSV-infected cells were analyzed by Western blotting using rabbit polyclonal antibodies against the His r Tag-UL13 fusion protein.
raised using antigen a recombinant His r Tag UL13 fu- ORF fused in frame at the 3* end of His r Tag sequence.
A diagram of the cloning scheme is shown in Fig. 1A.sion protein. For this purpose the HSV-1 UL 13 gene was
amplified by PCR using primers with either restriction High levels of the His r Tag-UL 13 fusion protein were
expressed in E. coli BL21 (DE3) following induction byendonuclease site of NdeI or SalI. The amplified DNA
was digested with NdeI and SalI and cloned into the pET IPTG (Fig. 1B). The protein was solubilized by sonication
in the presence of 1% NP-40, purified by a nickel-affinity28b expression vector under the control of the T7 RNA
polymerase promoter. The resulting plasmid pET UL13 column, and used for the production of anti-UL13 antise-
rum in rabbits.contained the complete sequence of the HSV-1 UL13
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FIG. 2. Induction of protein kinase activity in infected cells. Vero cells were mock-infected or infected with HSV-1 (A) or HSV-2 (B) at a multiplicity
of 5 PFU/cell and harvested at the indicated times after infection. The cells were separated into cytoplasmic (l, j) and nuclear (s, h) fractions.
Protein kinase activity of each fraction was measured by monitoring incorporation of 32P from [g-32P]ATP into TCA-precipitable materials under the
conditions described under Materials and Methods. Casein was used as a exogenous substrate.
To examine the reactivity and specificity of the anti- tide with an apparent molecular weight of 57 kDa which
was present in nuclear extracts of HSV-1-infected cellsUL13 antiserum, Western blot analysis was performed.
Vero cells were mock-infected or infected with HSV-1 or but not in those of mock-infected cells. The antiserum
could also react with a 56-kDa protein of HSV-2-infectedHSV-2 at a multiplicity of 5 PFU/cell and incubated for
18 hr at 377. The nuclear fractions of the mock-infected cells. Time course experiments showed that the 57-kDa
protein was detected after 8 hr postinfection, and thatand infected cells were prepared and the proteins of the
fractions were electrophoretically separated on poly- the intensity of the band increased gradually until 24 hr
postinfection (data not shown). These results are consis-acrylamide gels, transferred to Immobilon PVDF mem-
branes, and subjected to the Western blotting detection tent with those reported by Cunningham et al. (1992),
supporting that the rabbit antiserum recognized the UL13system using the anti-UL13 antiserum. As shown in Fig.
1C, the antiserum predominantly reacted with a polypep- proteins induced by HSV-1 and HSV-2.
TABLE 1
Purification of HSV-2 UL13 Protein Kinase
Volume Protein Activity Specific activity Purification
(ml) (mg)a (pmol/min) (pmol/min mg) (-fold)
Nuclear extract 320 1360 74764 55.0 1
Phosphocellulose 84 8.4 10994 1308.8 23.8
DEAE cellulose 18 3.6 6033 1675.8 30.5
Hydroxyapatite 7 0.25 1833 7332.0 133.3
a Protein concentration was estimated using Bradford protein assay kits (Bio-Rad) with BSA as the standard.
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activity in the nuclear extracts of mock-infected cells was
slightly higher than the background and remained ap-
proximately constant. The Western blot analysis shown
in Fig. 1C suggests that similar amounts of UL13 protein
were produced in HSV-1- and HSV-2-infected cells at
18 hr postinfection. However, the level of casein kinase
activity induced in HSV-1- and HSV-2-infected cells dif-
fered by approximately fivefold at 20 hr postinfection.
Although the reason is not clear yet, this might be due
to different substrate specificity and optimal conditions
of reaction.
In the above experiments, the casein kinase activity
was assayed in the absence of NaCl, and similar patterns
of the induction were obtained even when assayed in
the presence of 500 mM NaCl, although the activity was
FIG. 3. Purification and identification of the UL13 PK of HSV-2. Unin-
much lower at this concentration of NaCl (data notfected (lane 1) and infected (lane 2) Vero cells were separated into
shown).cytoplasmic and nuclear (lane 1 and 2) fractions. Nuclear extracts of
HSV-infected cells were subjected to successive chromatography on
phophocellulose (lane 3), DEAE-cellulose (lane 4), and hydroxyapatite
Purification of the UL13 PK(lane 5), as described under Materials and Methods. The peak fractions
of each chromatography were applied to SDS–PAGE, and the gels
Based on the above observations, we decided to purifywere stained with silver. The final preparation was analyzed by Western
the UL13 PK from the nuclear extracts of Vero cells in-blotting using rabbit polyclonal antibodies against the His r Tag-UL13
fusion protein (lane 6). fected for 20 hr with HSV-2. The nuclear extracts were
subjected to phosphocellulose column chromatography.
With casein as a substrate, one major peak with a minor
Induction of a nuclear PK by HSV-1 and HSV-2
second peak of protein kinase activity was observed in
the elution profile from the nuclear extracts (data notInduction of protein kinase activity was studied in nu-
clear and cytoplasmic extracts of mock-, HSV-1-, or HSV- shown). The major peak was eluted at 400 mM NaCl and
was found to contain the 56-kDa protein which reacted2-infected cells, using casein as a exogenous substrate.
Confluent monolayers of Vero cells were infected with with the anti-UL13 antiserum. Thus the first major peak
fractions of casein kinase activity were further subjectedeach virus, incubated at 377, and harvested for the assay
of protein kinase activity at various times after infection. to sequential column chromatography on DEAE-cellulose
and hydroxyapatite. In both DEAE-cellulose and hydroxy-High levels of casein kinase activity were induced in the
nuclei of HSV-2-infected cells and also a considerable apatite chromatography, we could observe a single major
peak of casein kinase activity, which contained the 56-increase of activity was observed in the cytoplasmic frac-
tion (Fig. 2). Whereas, in HSV-1-infected cells the induc- kDa protein. The whole steps of purification are summa-
rized in Table 1. The nuclear casein kinase was purifiedtion of casein kinase activity was not so conspicuous as
that observed with HSV-2. The level of the casein kinase approximately 130-fold in specific activity from the nu-
FIG. 4. Effect of NaCl (A), pH (B), and MgCl2 (C) on the activity of the UL13 PK. The enzyme preparation was assayed for protein kinase activity
with casein as substrate as described under Materials and Methods, except that the pH and the concentrations of NaCl and MgCl2 were varied
as indicated. The activity is expressed as percentage of the maximum values.
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ficity (Table 2). The HSV-2 UL13 PK efficiently phophory-
lated acidic proteins, casein and phosvitin, but did not
detectably phosphorylate a basic protein protamine
which is the best substrate for the HSV-2 US3 PK. How-
ever, histone, one of basic proteins, was a relatively good
substrate for the UL13 PK. Among a-, b-, and k-caseins,
b-casein was most efficiently phosphorylated by the
UL13 PK. The substrate specificity of the HSV-2 UL13 PK
was also similar to CK I rather than CK II.
Effects of inhibitors and activators on the activity of
the HSV-2 UL13 PK
The effects of various inhibitors and activators on pro-
tein kinase activities were examined in the standard
FIG. 5. Phosphoamino acid analysis of phosphorylated casein. Ca-
assay using casein as a substrate (Fig. 6). The HSV-2sein was phosphorylated in vitro by the purified HSV-2 UL13 PK and
UL13 PK was highly resistant to heparin, a potent inhibi-subjected to phosphoamino acid analysis as described under Materials
and Methods. Unlabeled phosphoserine (P-SER), phosphothreonine (P- tor of CK II, the activity of which was completely inhibited
THR), and phosphotyrosine (P-TYR) were used as markers. at 5 mg/ml (Fig. 6A). Approximately 80% of the UL13 PK
activity was retained even at 100 mg/ml heparin. At this
concentration the activity of CK I was inhibited by 60%.
clear extracts of HSV-2-infected cells. The final prepara- The UL13 PK also showed a relatively high resistance to
tion of the purified protein kinase contained one major CKI-7 (Fig. 6B), a synthetic inhibitor of CK I (Chijiwa et
protein of 56 kDa, which reacted with the anti-UL13 anti- al., 1989). Interestingly the UL13 PK, like the HSV-2 US3
serum (Fig. 3). PK (Daikoku et al., 1993), was very sensitive to quercetin,
a bioflavonoid; only 2 mM quercetin was required for 50%
Catalytic properties of the HSV-2 UL13 PK inhibition (Fig. 6C). Both CK I and CK II were much more
resistant to this compound.
The UL13 PK of HSV-2 was first characterized with The effects of other compounds are summarized in
respect to salt dependence, using casein as a substrate Table 3. The UL13 PK activity was slightly stimulated by
(Fig. 4A). Cellular CK I and CK II were used for compari- the addition of spermine and protamine, but no enhance-
son. The purified UL13 PK was sensitive to salt and was ment was observed by the addition of cAMP and CaCl2 .most active in the absence of NaCl. At 500 mM NaCl Polyarginine has been shown to inhibit the HSV-2 US3
the activity was inhibited by about 70%. In contrast, The PK; at 200 mg/ml more than 50% of the activity is inhibited.
activity of CK II was strikingly stimulated by the addition However, polyarginine and polylysine exhibited no or
of NaCl and was optimal at 200 mM, but in the presence only slight inhibitory effect on the activity of the UL13 PK
of 500 mM NaCl almost no activity was detectable. The and CK I, while both enhanced the activity of CK II. N-
CK I activity was also stimulated by 200 mM NaCl but to ethylmaleimide, a SH group blocker, inhibited the en-
a much lesser extent. At 500 mM, the CK I, like the UL13 zyme activity, indicating that the SH group plays a role
PK, was inhibited by 70%. The pattern of salt dependence in the phosphate transfer reaction of the UL13 PK. Sphin-
of the UL13 PK was similar to that of CK I rather than
that of CK II. All of three PKs were active over a broad
pH range, but the optimal pH was different (Fig. 4B). The TABLE 2
optimal pH of the UL13 PK, CK I, and CK II was around
Substrate Specificity of HSV-2 UL13 Protein Kinase,
pH 9.0, 6.8, and 8.4, respectively. The UL13 PK, like other Protein Kinase CK I, and CK II
protein kinases, had an absolute requirement for divalent
Percentage of activitycations. The optimum concentration of Mg2/ was be-
tween 10 and 20 mM (Fig. 4C).
UL13 PK CK I CK IITo determine which amino acid residues of casein
were phosphorylated by the UL13 PK, reaction was car- Casein 100 100 100
ried out under the optimal conditions of the enzyme, and a-Casein 52 43 3
b-Casein 118 129 68phosphorylated casein was analyzed by phosphoamino
k-Casein 79 167 37acid analysis (Fig.5). The casein was found to be mainly
Histone 86 85 16phosphorylated at serine residues with a minor degree
Protamine 3 3 3
of phosphorylation at threonine residues, but there was Phosvitin 63 94 30
no detectable phosphorylation at s tyrosine residue.
Note. Reaction conditions are given under Materials and Methods.We next characterized the UL13 PK on substrate speci-
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FIG. 6. Effect of heparin (A), CKI-7 (B), and quercetin (C) on the activity of the UL13 PK. Reactions were performed using casein as substrate as
described under Materials and Methods, except that the inhibitors were added at the concentrations indicated.
gosine, an inhibitor of protein kinase C, did not show into pACYC184 (Tsurumi et al., 1986), as described under
Materials and Methods. Figure 7 presents the amino acidany significant inhibitory effect, but H-9, a potent inhibitor
of cyclic nucleotide-dependent PKs, and staurosporin, a sequences in the one-letter notation of the polypeptide
predicted for the HSV-2 UL13 PK. The UL13 protein ofpotent inhibitor of protein kinase C and cyclic nucleotide-
dependent kinases, moderately inhibited the UL13 PK at HSV-2 consisted of 518 amino acids and had a deduced
molecular weight of 57,045 in agreement with the appar-relatively high concentrations of these inhibitors. More-
over, the incorporation of [g-32P] into the substrate was ent molecular weight of 56 kDa for the purified enzyme.
The calculated isoelectric point was 10.68 and slightlyfound to be suppressed by the addition of ATP but not
GTP, suggesting that the UL13 PK does not utilize GTP higher than that of the HSV-1 UL13. The overall amino
acid homology between the HSV-1 and HSV-2 UL13 PKsas a phosphate donor.
was 85.9%. The homology was highly conserved in the
Amino acids sequence of the HSV-2 UL13 PK C-terminal region of the UL13 protein; the homology of
the C-terminal 150 amino acids was 92%, while that ofWe have determined the nucleotide sequence of the
the N-terminal 150 amino acids was 73.3%. The 47 aminoUL13 region of the genome from a plasmid clone con-
acids between residues 427 and 483 were completelytaining a HindIII B fragment of HSV-2 strain 186 inserted
identical to each other. When the predicted amino acid
sequences were compared with those of other PK family
TABLE 3 members, major subdomains which are conserved in
various PKs could be readily identified, but a few subdo-Effect of Various Protein Kinase Activators and Inhibitors on HSV-2
mains were difficult to be exactly assigned. AlthoughUL13 Protein Kinase, Protein Kinase CK I, and CK II
the UL13 PKs are among the few known kinases with
Percentage activity specificity for acidic substrates, they are quite distinct
from cellular CKI and CKII families in terms of primary
Activators or inhibitors CK I CK II UL13 PK
sequence.
Spermine (0.5 mM) 115 83 120
(5 mM) 110 50 116 DISCUSSION
Protamine (100 mg/ml) 111 126 109
The present study demonstrates that PK encoded bycAMP (10 mM) 99 107 100
CaCl2 (1 mM) / Calmodulin (0.01 mM) 93 90 97 the UL13 gene of HSV-2 had distinct properties from
Poly-L-arginine (200 mg/ml) 98 144 99 those of cellular PKs and viral PK encoded by the US3
Poly-L-lysine (200 mg/ml) 99 170 90 gene. When Vero cells were infected with HSV-1 and
N-ethylmaleimide (10 mM) 52 65 52
HSV-2, novel casein kinase activity was induced at theH-9 (100 mM) 62 93 74
late stage of infection and the most striking inductionStaurosporin (20 mM) 101 98 76
Sphingosine (100 mg/ml) 100 94 103 was observed in the nuclear fractions of HSV-2-in-
ATP (0.2 mM) 49 34 40 fected cells. We therefore tried to purify the virus-in-
(1 mM) 8 9 12 duced PK from the nuclear extracts of HSV-2-infected
GTP (0.2 mM) 97 60 98
cells harvested at 20 hr postinfection. The purified(1 mM) 90 22 86
preparation contained a single major protein with an
Note. Reaction conditions are given under Materials and Methods. apparent molecular weight of 56 kDa which was specif-
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FIG. 7. The predicted amino acid sequence of the HSV-2 UL13 PK. The sequence is presented in the single-letter code and amino acids are
numbered at the left end of each line. The amino acid which differed from that presented in HSV-1 strain KOS are indicated by aristrics. Underlined
residues correspond to readily identifiable conserved subdomains of protein kinases (Hanks et al., 1988). Subdomains are numbered below the
sequence.
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ically reacted with the antiserum against the His r by basic or acidic residues situated in the proximity of
the target residues and the overall acidic nature of theTag-UL13 fusion protein. Previously, Cunningham et
al. (1992) have also reported the induction of a nuclear substrates of casein kinases is echoed by the pres-
ence of acidic residues in the vicinity of the targetPK by HSV-1. In their study, however, the PK activity in
nuclear extracts rapidly increases at the early step of residues (Kuenzel et al., 1987; Marin et al., 1986). For
these acidtropic protein kinases, it is becoming appar-infection and reached the peak by 6 hr postinfection.
The PK efficiently phosphorylates an endogenous pro- ent that phosphate groups are important elements of
substrate recognition, in some cases more critical thantein with a molecular weight of 57 kDa, which was
found to be the UL 13 product itself. The enzyme is the directly coded acidic residues Asp and Glu (Flotow
et al., 1990). At present we cannot yet define the sub-able to also phosphorylate exogenous casein, can use
ATP or GTP as a phosphate donor, is stimulated by strate determinants for the HSV UL13 PK. It will be
interesting to determine whether the UL13 PK requireshigh concentrations of NaCl (1.5 M), and is resistant
to inhibition by heparin. The UL13 PK purified by us prior phosphorylation of substrates.
The UL 13 proteins of HSV-2 consisted of 528 aminowas different from that enzyme in some important prop-
erties. Our enzyme was sensitive to NaCl, that is, the acids and had the same size as the HSV-1 counterpart.
The amino acid homology between the HSV-1 andaddition of 1 M NaCl inhibited the PK activity by more
than 80%. In addition, the PK did not appear to utilize HSV-2 PKs was 85.9%, which was a relatively high
value among that of the other known proteins encodedGTP as a phosphate donor. The reason for these differ-
ences remained unknown, but a possible explanation by HSV-1 and HSV-2, for example, such values for the
amino acid differences for thymidine kinase, glycopro-is that we used a purified preparation and exogenous
casein as a substrate to characterize the enzyme while tein C, alkaline nuclease, and DNA polymerase are 73,
73, 81, and 90.9%. A large number of protein kinase-previous researchers studied endogenous protein
phosphorylation using nuclear extracts of infected related genes have been sequenced and analyzed on
their amino acid sequence patterns. Hanks et al. (1988)cells. In their case, it may be difficult to rule out that
cellular PKs are responsible for the phosphorylation of have reported the identification of 11 conserved re-
gions in the catalytic domains of PKs on the basis ofendogenous proteins. Another possibility is that we
used the enzyme purified from HSV-2-infected cells. It an alignment of 65 different members of the PK family.
The UL13 PKs have many of the sequence featuresis known that some HSV-2-induced enzymes are differ-
ent from their HSV-1 counterparts in some respects. that are highly conserved in all PKs and match the
serine/threonine kinase pattern. The motif, Gly-X-Gly-For example, HSV-1-specific thymidine kinase has
dTMP kinase activity while the HSV-2 enzyme does not X-X-Gly, recognized in many nucleotide-binding pro-
tein, was found in subdomain I and a lysine residue at(Fyfe, 1982); HSV-2 encodes a deoxyuridine triphos-
phate which, in contrast to the type 1 enzyme, fraction- position 176, which has been suggested to be directly
involved in the phosphotransfer reaction, was found inates into the cytoplasma (Wohlrab et al., 1982). How-
ever, the properties of partially purified HSV-1 UL13 PK subdomain II. However, the consensus triplets Asp-
Phe-Gly in subdomain VII and Ala-Pro-Glu in subdo-was similar to those of the HSV-2 enzyme although the
HSV-1 preparation used was much lower in specific main VIII were not conserved in the HSV UL13 PKs
although the Asp-Phe-Ser and Pro-Pro-Glu aligned atactivity than that of the HSV-2 preparation (data not
shown). It seems unlikely that the differences are at- the locations may fit the consensus triplets, respec-
tively. The Ala-Pro-Glu consensus is very important intributed to difference of HSV types.
When the properties of the HSV-2 UL13 PK were catalysis (Hanks et al., 1988) and mutagenesis studies
have shown that each residue in this triplet is essentialcompared with those of cellular CK I and CK II, the
HSV PK resembled CK I rather than CK II. The UL 13 for activity of v-Src (Bryant and Parsons, 1983). Al-
though the UL13 PK has Pro instead of Ala, the functionPK, like CK I, were insensitive to heparin, a potent
inhibitor of CK II, did not utilize GTP, and were not of this subdomain is considered to be unchanged. It
would be interesting to note that protein kinases be-stimulated by polyarginine and polylysine. However,
the viral PK was much more resistant to a specific CK longing to the CK I family also lack the Ala-Pro-Glu
motif in subdomain VIII (Graves et al., 1993). Subdo-I inhibitor, CK I-7, and was more sensitive to quercetin.
There was also a significant difference among these main IX contains a well-conserved short stretch which
includes the nearly invariant residues correspondingPKs in salt sensitivity. These data would be useful to
differentiate the UL13 PK activity from multifunctional to Asp and Gly and was readily recognized in the UL13,
while it was difficult to localize the subdomain X andand ubiquitous CK I and CK II. As regards the substrate
specificity, we found that the UL13 PK preferred a- XI. The latter must contain an invariant Arg near the
catalytic domain carboxy terminus. The most possiblecasein to b- and k-caseins and phosvitin. Most Ser/
Thr protein kinases including CK I and CK II have been candidate may be the arginine at position 505. Since
the UL13 gene product not only acts as protein kinaseshown to recognize consensus sequences specified
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herpes simplex virus type 1 and type 2 alkaline exonuclease andbut also is a structural component of the virion, the
overlapping proteins. J. Virol. 57, 1023–1036.conservation and divergence of the amino acid se-
Flotow, H., Graves, P. R., Wang, A., Fiol, C. J., Roeske, R. W., and Roach,
quences of the UL13 PKs should be considered from P. J. (1990). Phosphate group as substrate determinants for casein
both points of view. kinase I action. J. Biol. Chem. 265, 14264–14269.
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